Literature DB >> 18456750

Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.

M Mandalà1, A Falanga, F Roila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18456750     DOI： 10.1093/annonc/mdn110

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  13 in total

Review 1.  Cancer, clots and consensus: new understanding of an old problem.

Authors:  Gary H Lyman; Alok A Khorana
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

2.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

3.  Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial.

Authors:  Jeffrey I Zwicker; Joanna Roopkumar; Maneka Puligandla; Benjamin L Schlechter; Anish V Sharda; David Peereboom; Robin Joyce; Bruno Bockorny; Donna Neuberg; Kenneth A Bauer; Alok A Khorana
Journal:  Blood Adv       Date:  2020-05-26

Review 4.  Venous thromboembolism and cancer: a systematic review.

Authors:  Celso Arrais Rodrigues; Renata Ferrarotto; Roberto Kalil Filho; Yana A S Novis; Paulo M G Hoff
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

5.  Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.

Authors:  Casey O'Connell; Carmen P Escalante; Samuel Z Goldhaber; Robert McBane; Jean M Connors; Gary E Raskob
Journal:  Oncologist       Date:  2020-12-04

6.  Overall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosis.

Authors:  Thita Chiasakul; Robert Redd; Rushad Patell; Adeel M Khan; Ellen P McCarthy; Donna Neuberg; Jeffrey I Zwicker
Journal:  J Thromb Haemost       Date:  2021-09-21       Impact factor: 5.824

Review 7.  International recommendations for the prevention and treatment of venous thromboembolism associated with cancer.

Authors:  Parham Khosravi-Shahi; Gumersindo Pérez-Manga
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

8.  Prevention and treatment of venous thromboembolism in patients with cancer.

Authors:  William M Semchuk; Catherine Sperlich
Journal:  Can Pharm J (Ott)       Date:  2012-01

Review 9.  Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.

Authors:  Alok A Khorana; Michael B Streiff; Dominique Farge; Mario Mandala; Philippe Debourdeau; Francis Cajfinger; Michel Marty; Anna Falanga; Gary H Lyman
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

10.  Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies.

Authors:  M Mandalà; F Grosso; C Vitalini; I Corradino; R Sanfilippo; S Colombini; M Clerici; R Labianca; A De Pascale; S Marsoni
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.